New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
A 'smashing' solution for cancer therapy

A 'smashing' solution for cancer therapy

byKyoto UniversityNew cancer therapy model in which endogenous PD-1 in mice can be degraded for only a necessary period of time. Credit: KyotoUSometimes too much of a good thing is not good at a
World medicine December 15,2023
A 'smashing' solution for cancer therapy

A 'smashing' solution for cancer therapy

byKyoto UniversityNew cancer therapy model in which endogenous PD-1 in mice can be degraded for only a necessary period of time. Credit: KyotoUSometimes too much of a good thing is not good at a
World medicine December 15,2023
Annual screening before age 50 leads to lower proportions of advanced breast cancer

Annual screening before age 50 leads to lower proportions of advanced breast cancer

byUniversity of OttawaStage–specific distribution of female breast cancer cases, ages 40 to 49 years versus ages 50 to 59 years, Canada excluding Quebec, 2010 to 2017. Note: Quebec is excluded b
World medicine December 15,2023
Annual screening before age 50 leads to lower proportions of advanced breast cancer

Annual screening before age 50 leads to lower proportions of advanced breast cancer

byUniversity of OttawaStage–specific distribution of female breast cancer cases, ages 40 to 49 years versus ages 50 to 59 years, Canada excluding Quebec, 2010 to 2017. Note: Quebec is excluded b
World medicine December 15,2023
Robotic-assisted lobectomy provides better patient-reported quality of life compared to video-assisted lobectomy

Robotic-assisted lobectomy provides better patient-reported quality of life compared to video-assisted lobectomy

by International Association for the Study of Lung CancerCredit: CC0 Public DomainRobot-assisted lung surgery is a cost-effective intervention that yields better patient-reported quality of life measu
World medicine December 15,2023
Robotic-assisted lobectomy provides better patient-reported quality of life compared to video-assisted lobectomy

Robotic-assisted lobectomy provides better patient-reported quality of life compared to video-assisted lobectomy

by International Association for the Study of Lung CancerCredit: CC0 Public DomainRobot-assisted lung surgery is a cost-effective intervention that yields better patient-reported quality of life measu
World medicine December 15,2023
Diet high in n-3-PUFAs linked to lower breast cancer risk

Diet high in n-3-PUFAs linked to lower breast cancer risk

A diet high in n-3 polyunsaturated fatty acids (PUFAs) is associated with a reduced risk for breast cancer among women in China, according to a study published online July 26 inMenopause.Zhuo-Li
World medicine December 15,2023
Diet high in n-3-PUFAs linked to lower breast cancer risk

Diet high in n-3-PUFAs linked to lower breast cancer risk

A diet high in n-3 polyunsaturated fatty acids (PUFAs) is associated with a reduced risk for breast cancer among women in China, according to a study published online July 26 inMenopause.Zhuo-Li
World medicine December 15,2023
Protein that detects light may play a role in the origin and progression of melanoma, study suggests

Protein that detects light may play a role in the origin and progression of melanoma, study suggests

by Julia Moióli,FAPESPResearchers at the University of São Paulo showed, through experiments on animals and genetically modified cells, that this type of cancer advances more slowly when the lig
World medicine December 15,2023
Protein that detects light may play a role in the origin and progression of melanoma, study suggests

Protein that detects light may play a role in the origin and progression of melanoma, study suggests

by Julia Moióli,FAPESPResearchers at the University of São Paulo showed, through experiments on animals and genetically modified cells, that this type of cancer advances more slowly when the lig
World medicine December 15,2023
FDA approves first targeted therapy for HER2-low breast cancer

FDA approves first targeted therapy for HER2-low breast cancer

The U.S. Food and Drug Administration has approved Enhertu (am-trastuzumab-deruxtecan-nxki), an intravenous infusion treatment for patients with unresectable or metastatic human epidermal growth facto
World medicine December 15,2023
FDA approves first targeted therapy for HER2-low breast cancer

FDA approves first targeted therapy for HER2-low breast cancer

The U.S. Food and Drug Administration has approved Enhertu (am-trastuzumab-deruxtecan-nxki), an intravenous infusion treatment for patients with unresectable or metastatic human epidermal growth facto
World medicine December 15,2023
Making better, ready-made CAR T cells for cancer immunotherapy

Making better, ready-made CAR T cells for cancer immunotherapy

byChildren's Hospital BostonCredit: CC0 Public DomainIn CAR T-cell immunotherapy, T cells from a patient's own blood are engineered to carry so-called chimeric antigen receptors (CAR) th
World medicine December 15,2023
Making better, ready-made CAR T cells for cancer immunotherapy

Making better, ready-made CAR T cells for cancer immunotherapy

byChildren's Hospital BostonCredit: CC0 Public DomainIn CAR T-cell immunotherapy, T cells from a patient's own blood are engineered to carry so-called chimeric antigen receptors (CAR) th
World medicine December 15,2023
New AI technology integrates multiple data types to predict cancer outcomes

New AI technology integrates multiple data types to predict cancer outcomes

byBrigham and Women's HospitalCredit: Pixabay/CC0 Public DomainWhile it's long been understood that predicting outcomes in patients with cancer requires considering many factors, such as
World medicine December 15,2023
New AI technology integrates multiple data types to predict cancer outcomes

New AI technology integrates multiple data types to predict cancer outcomes

byBrigham and Women's HospitalCredit: Pixabay/CC0 Public DomainWhile it's long been understood that predicting outcomes in patients with cancer requires considering many factors, such as
World medicine December 15,2023
Abortion ban may increase risk of death for pregnant women with cancer

Abortion ban may increase risk of death for pregnant women with cancer

by Melinda Krigel,University of California, San FranciscoCredit: Pixabay/CC0 Public DomainThe repercussions of overturning Roe v. Wade—and the failure of the Supreme Court to provide any guidanc
World medicine December 15,2023
Abortion ban may increase risk of death for pregnant women with cancer

Abortion ban may increase risk of death for pregnant women with cancer

by Melinda Krigel,University of California, San FranciscoCredit: Pixabay/CC0 Public DomainThe repercussions of overturning Roe v. Wade—and the failure of the Supreme Court to provide any guidanc
World medicine December 15,2023
Phase 3 clinical trial: Brain cancer vaccine shows promising results

Phase 3 clinical trial: Brain cancer vaccine shows promising results

byKing's College LondonOverall Survival for Patients With Recurrent Glioblastoma Kaplan-Meier plot comparing overall survival for patients with recurrent glioblastoma treated with autologous
Oncology December 15,2023
Phase 3 clinical trial: Brain cancer vaccine shows promising results

Phase 3 clinical trial: Brain cancer vaccine shows promising results

byKing's College LondonOverall Survival for Patients With Recurrent Glioblastoma Kaplan-Meier plot comparing overall survival for patients with recurrent glioblastoma treated with autologous
Oncology December 15,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com